| Value | ₹24.60 Cr |
|---|
BSE filing, NSE: GEMSI. Summary written from the filing by ALFA Finder's alert engine.
Gemstone Investments Ltd: key numbers
- Share price
- ₹1.24
- Market cap
- ₹9.27 Cr
- Revenue (annual)
- ₹2.23 Cr
- Net profit (annual)
- ₹0.40 Cr
- P/E (TTM)
- 8.0×Sector 19.8×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Gemstone Investments Ltd
All →Gemstone Investments Other Announcement
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026, noting the conversion of 393.6 million warrants into equity shares.
Gemstone Investments Annual General Meeting
Gemstone Investments Limited held its 32nd Annual General Meeting on 29th September 2026. The meeting transacted ordinary business, including the approval of audited financial statements.
Gemstone Investments Annual Report
Gemstone Investments Limited has submitted a revised Annual Report for the financial year 2025-26. The filing also includes a corrigendum regarding the upcoming AGM venue change.
Gemstone Investments Annual General Meeting
Gemstone Investments issued a corrigendum notifying shareholders of a change in venue for the 32nd Annual General Meeting scheduled for September 29, 2026.
Gemstone Investments Annual Report
Gemstone Investments Limited has submitted its Annual Report for the Financial Year 2025-26, along with the notice for its 32nd Annual General Meeting.
Gemstone Investments Annual General Meeting
Gemstone Investments Ltd has issued the notice for its 32nd Annual General Meeting, scheduled for September 29, 2026. The meeting will address ordinary business.
Other fund raise announcements
All →Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.
Gujarat Inject (Kerala) Fund Raise of ₹3 Cr
Gujarat Inject Kerala's board approved a Rs.3 Crore preferential warrant issue to public investors. Authorised capital will rise to Rs.17.63 Crore, subject to shareholder approval.
- Value
- ₹3.00 Cr